全文获取类型
收费全文 | 7830篇 |
免费 | 582篇 |
国内免费 | 34篇 |
专业分类
耳鼻咽喉 | 152篇 |
儿科学 | 163篇 |
妇产科学 | 85篇 |
基础医学 | 1307篇 |
口腔科学 | 51篇 |
临床医学 | 883篇 |
内科学 | 2034篇 |
皮肤病学 | 103篇 |
神经病学 | 861篇 |
特种医学 | 273篇 |
外国民族医学 | 3篇 |
外科学 | 1000篇 |
综合类 | 23篇 |
预防医学 | 562篇 |
眼科学 | 88篇 |
药学 | 446篇 |
中国医学 | 11篇 |
肿瘤学 | 401篇 |
出版年
2023年 | 35篇 |
2022年 | 51篇 |
2021年 | 189篇 |
2020年 | 99篇 |
2019年 | 193篇 |
2018年 | 213篇 |
2017年 | 131篇 |
2016年 | 149篇 |
2015年 | 210篇 |
2014年 | 304篇 |
2013年 | 343篇 |
2012年 | 571篇 |
2011年 | 542篇 |
2010年 | 324篇 |
2009年 | 290篇 |
2008年 | 491篇 |
2007年 | 496篇 |
2006年 | 467篇 |
2005年 | 488篇 |
2004年 | 463篇 |
2003年 | 457篇 |
2002年 | 431篇 |
2001年 | 105篇 |
2000年 | 92篇 |
1999年 | 123篇 |
1998年 | 106篇 |
1997年 | 80篇 |
1996年 | 64篇 |
1995年 | 64篇 |
1994年 | 55篇 |
1993年 | 21篇 |
1992年 | 67篇 |
1991年 | 49篇 |
1990年 | 66篇 |
1989年 | 63篇 |
1988年 | 66篇 |
1987年 | 51篇 |
1986年 | 47篇 |
1985年 | 45篇 |
1984年 | 30篇 |
1983年 | 31篇 |
1982年 | 26篇 |
1981年 | 16篇 |
1980年 | 16篇 |
1979年 | 34篇 |
1978年 | 32篇 |
1977年 | 31篇 |
1976年 | 14篇 |
1975年 | 23篇 |
1971年 | 14篇 |
排序方式: 共有8446条查询结果,搜索用时 0 毫秒
991.
992.
993.
994.
Medeiros de Bustos E Vuillier F Chavot D Moulin T 《Presse medicale (Paris, France : 1983)》2012,41(5):514-517
Telemedicine covers different fields going from teleconsultation to tele expertise. Thanks to different national and international studies, telemedicine applied to stroke (telestroke) should be considered as reliable, sure and efficient. Securized specific networks and standardised procedures are required. Telestroke can be used at each stage of stroke and every kind of stroke can benefit this technic. The main limitation is the lack of specific financial retribution. 相似文献
995.
Kamar N Rostaing L Cassuto E Villemain F Moal MC Ladrière M Barrou B Ducloux D Chaouche K Quéré S Di Giambattista F Be F 《Clinical nephrology》2012,77(2):126-136
Mycophenolic acid (MPA) dose is frequently reduced in tacrolimus-treated kidney transplant patients, but alternatively the recommended MPA dose can be maintained with reduced tacrolimus exposure. In a 6-month, multicenter, randomized, openlabel study, maintenance kidney transplant patients receiving MPA (mycophenolate mofetil 1g/d or enteric-coated mycophenolate sodium (EC-MPS) 720 mg/d) and tacrolimus were randomized to convert to EC-MPS 1,440 mg/d with reduced tacrolimus (n = 46), or receive EC-MPS 720 mg/d with unchanged tacrolimus (n = 48). Mean estimated GFR (eGFR, aMDRD) at Month 6 was 49.1 ± 11.1 and 44.7 ± 11.5 ml/min/1.73 m2 in the EC-MPS 1,440 mg and 720 mg groups, respectively (p = 0.07). The primary endpoint, change in eGFR from Day 0 to Month 6, was 2.48 ± 0.95 ml/min/1.73 m2 with EC-MPS 1,440 mg and -0.48 ± 0.93 ml/min/1.73 m2 with EC-MPS 720 mg (difference 2.96 ml/min/1.73 m2; 95% CI 0.32 - 5.60; p = 0.028). There were no deaths, graft losses or acute rejections. Adverse events were more frequent with EC-MPS 1,440 mg than 720 mg (66.7% vs. 44.7%, p = 0.034). Adverse events with suspected relation to EC-MPS occurred in 26.7% and 21.3% of patients, respectively (p = 0.59). Conversion of kidney transplant patients to increased MPA dosing using EC-MPS 1,440 mg/d, with reduced tacrolimus exposure, appears an effective immunosuppression strategy and may improve renal function. Adverse events overall, but not those with a suspected relation to EC-MPS, were higher with ECMPS 1,440 mg/d. 相似文献
996.
Q Hassan B Roche C Buffet T Bessede D Samuel B Charpentier A Durrbach 《Transplant international》2012,25(9):941-947
Antiviral therapy with interferon-alpha (IFN-alpha) and pegylated IFN-alpha (PEG-IFN-alpha) for chronic hepatitis C (HCV)-infected kidney recipients remains controversial. IFN-alpha is not recommended in most cases because it induces severe acute graft rejection. However, IFN-alpha, as PEG-IFN-alpha, is associated with a more pronounced immune response, and is well tolerated in HCV-infected liver recipients without causing graft rejection. In combined liver-kidney transplant (LKT) recipients, IFN-alpha has been occasionally used and appears to be well tolerated. All LKT recipients with a functioning kidney and liver having a HCV replication and who needed IFN-alpha therapy have been included in the study. The occurrence of liver and/or renal acute rejection as well as the HCV replication has been collected. A total of 12 LKT patients treated with PEG-IFN-alpha plus ribavirin have been studied. No acute rejection was observed. Renal function remained stable during and after discontinuing treatment, without any graft dysfunction. Two patients had a partial viral response and four had a sustained viral response. All patients, whatever their viral response, had decreased liver-enzyme levels. Response to PEG-IFN-alpha therapy was correlated with steroid dose and transaminase level when PEG-IFN-alpha was started. These data suggest that the combination therapy of PEG-IFN-alpha plus ribavirin did not have a higher risk of acute kidney-graft rejection after liver-kidney transplantation. 相似文献
997.
Daniel Ciampi de Andrade Alaa Mhalla Frédéric Adam Manoel Jacobsen Texeira Didier Bouhassira 《Pain》2014
We investigated the role of glutamate N-methyl-d-aspartate (NMDA) receptors in the analgesic effects induced by repetitive transcranial magnetic stimulation (rTMS). In a randomized, double-blind, crossover study, we compared the effects of ketamine and placebo on the analgesic effects of motor cortex (M1) or dorsolateral prefrontal cortex/premotor cortex (DLPFC/PMC) stimulation. Three groups of 12 healthy volunteers underwent active rTMS (10 Hz, 80% resting motor threshold, 1,500 pulses per session) of the right M1, active stimulation of the right DLPFC/PMC, or sham stimulation during 2 experimental sessions 2 weeks apart. Cold pain thresholds were measured on the left thenar eminence before and 1 hour after cortical stimulation, to evaluate the analgesic effects of rTMS. Ketamine (0.15 mg/kg in a 10-minute bolus followed by continuous infusion of 6 μg/kg per minute until the end of rTMS) or placebo (saline) were administered intravenously during cortical stimulation. We also systematically measured cortical excitability parameters (resting motor threshold, suprathreshold motor-evoked potentials, short intracortical inhibition, and intracortical facilitation) before and after treatment, to investigate the possible relationship between changes in cortical excitability and rTMS-induced analgesia. Ketamine injection significantly decreased the analgesic effects of both M1 and DLPFC/PMC stimulation. The decrease in the analgesic effect of rTMS was not associated with changes in cortical excitability parameters, which were not influenced by rTMS following the administration of either saline or ketamine. Thus, rTMS-induced analgesia depends on glutamate NMDA receptors and may involve long-term potentiation-like mechanisms. 相似文献
998.
Miroslav ‘‘Misha’’ Bačkonja Nadine Attal Ralf Baron Didier Bouhassira Mark Drangsholt Peter J. Dyck Robert R. Edwards Roy Freeman Richard Gracely Maija L. Haanpaa Per Hansson Samar M. Hatem Elena K. Krumova Troels S. Jensen Christoph Maier Gerard Mick Andrew S.C. Rice Roman Rolke Jordi Serra Thomas R. Tolle Rolf-Detlef Treede Valeria Tugnoli David Walk Mark S. Wallace Mark A. Ware David Yarnitsky Dan Ziegler 《Pain》2014
999.